GSK

GlaxoSmithKline CEO Walmsley: COVID-19 is pharma's chance for redemption
GlaxoSmithKline CEO Walmsley: COVID-19 is pharma's chance for redemption
Fierce Pharma
GSK
Pharma CEOs
Emma Walmsley
pandemic
COVID-19
Flag link:
Fourth-quarter events to watch for big pharma
Fourth-quarter events to watch for big pharma
EP Vantage
COVID-19
clinical trials
AstraZeneca
Gilead Sciences
Takeda
GSK
Roche
Alzheimer's disease
Bristol-Myers Squibb
Pfizer
Eli Lilly
Flag link:
GlaxoSmithKline's Nucala targets rival AstraZeneca with FDA nod for rare white blood cell disease
GlaxoSmithKline's Nucala targets rival AstraZeneca with FDA nod for rare white blood cell disease
Fierce Pharma
GSK
Nucala
hypereosinophilic syndrome
FDA
AstraZeneca
Flag link:
Drugmakers push forward on large-scale production of coronavirus vaccines
Drugmakers push forward on large-scale production of coronavirus vaccines
BioPharma Dive
vaccines
Operation Warp Speed
COVID-19
Pfizer
Moderna Therapeutics
AstraZeneca
Merck
JNJ
Novavax
GSK
Sanofi
Flag link:
Sanofi, GSK sign agreements with Government of Canada to supply 72 million doses of adjuvanted Covid-19 vaccine
Sanofi, GSK sign agreements with Government of Canada to supply 72 million doses of adjuvanted Covid-19 vaccine
Pharmaceutical Business Review
COVID-19
vaccines
Canada
Sanofi
GSK
Flag link:
FDA approves Trelegy Ellipta as once-daily single inhaler triple therapy for asthma and COPD
FDA approves Trelegy Ellipta as once-daily single inhaler triple therapy for asthma and COPD
Pharmaceutical Business Review
GSK
Innovia
Trelegy Ellipta
COPD
asthma
FDA
Flag link:
COVID-19 vaccine CEOs vow to wait for phase 3 data before filing for approval
COVID-19 vaccine CEOs vow to wait for phase 3 data before filing for approval
Fierce Pharma
COVID-19
vaccines
Operation Warp Speed
Donald Trump
AstraZeneca
Pfizer
BioNTech
GSK
JNJ
Merck
Moderna Therapeutics
Novavax
Sanofi
Flag link:
Big pharma spinouts grow up
Big pharma spinouts grow up
EP Vantage
Big Pharma
spinoffs
Merck KGaA
Pfizer
GSK
Novartis
Roche
Sanofi
JNJ
AstraZeneca
Flag link:
Sanofi, GSK, racing to catch up, begin their first human study of coronavirus vaccine
Sanofi, GSK, racing to catch up, begin their first human study of coronavirus vaccine
BioPharma Dive
Sanofi
GSK
COVID-19
vaccines
clinical trials
Flag link:
Building up its AI operations, GSK opens a $13M London hub with plans to woo talent now trekking to Silicon Valley
Building up its AI operations, GSK opens a $13M London hub with plans to woo talent now trekking to Silicon Valley
Endpoints
GSK
London
artificial intelligence
Flag link:
Vir and GlaxoSmithKline begin pivotal study of Covid-19 antibody drug
Vir and GlaxoSmithKline begin pivotal study of Covid-19 antibody drug
Stat
Vir Biotechnology
GSK
clinical trials
antibodies
COVID-19
Flag link:
Ionis deal delivers for GSK as HBV drug hits the mark in phase 2
Ionis deal delivers for GSK as HBV drug hits the mark in phase 2
Pharmaforum
GSK
antisense
hepatitis B
clinical trials
GSK3228836
Ionis Pharmaceuticals
Flag link:
EASL 2020 – Assembly finds a partner as hepatitis B inches forward
EASL 2020 – Assembly finds a partner as hepatitis B inches forward
EP Vantage
EASL
RNAi
hepatitis B
Assembly Biosciences
Abrutus
JNJ
GSK
Vir Biotechnology
Flag link:
Phase 3 wins put Dermavant closer to filing Otezla rival tapinarof
Phase 3 wins put Dermavant closer to filing Otezla rival tapinarof
Pharmaforum
Dermavant
GSK
tapinarof
psoriasis
Otezla
clinical trials
Flag link:
New GSK campaign works to raise adult vaccine awareness—and counter COVID-19 slump
New GSK campaign works to raise adult vaccine awareness—and counter COVID-19 slump
Fierce Pharma
DTC advertising
GSK
vaccines
COVID-19
Flag link:
Boehringer calls off €627M deal with GSK spinout, passing on schizophrenia drug option
Boehringer calls off €627M deal with GSK spinout, passing on schizophrenia drug option
Endpoints
Boehringer Ingelheim
GSK
schizophrenia
Autifony
AUT00206
Flag link:
These 4 Drugmakers Are Using AI to Improve Their Products. Does It Make Them Better Buys?
These 4 Drugmakers Are Using AI to Improve Their Products. Does It Make Them Better Buys?
Motley Fool
artificial intelligence
drug development
AstraZeneca
GSK
Novartis
Eli Lilly
Flag link:
Pfizer, Merck, and Others See a Slowdown in Vaccine Sales, but Anticipate an Autumn Rebound
Pfizer, Merck, and Others See a Slowdown in Vaccine Sales, but Anticipate an Autumn Rebound
Motley Fool
Pfizer
Merck
Sanofi
GSK
vaccines
Flag link:
FDA approves GSK's BCMA drug, marking a rocky return to cancer for the British giant
FDA approves GSK's BCMA drug, marking a rocky return to cancer for the British giant
Endpoints
GSK
FDA
Multiple Myeloma
belantamab mafodotin
Flag link:
Sanofi, GlaxoSmithKline disclose DOJ investigation into Zantac after recalls
Sanofi, GlaxoSmithKline disclose DOJ investigation into Zantac after recalls
Fierce Pharma
Sanofi
GSK
FDA
Zantac
DOJ
cancer
product recalls
False Claims Act
Flag link:

Pages